Evidence map›Paper›PMID 23696797›Full record

ArticlePloS one2013

Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study.

Martha L Slattery, Esther John, Gabriela Torres-Mejia, Mariana Stern, Abbie Lundgreen, Lisa Hines, Anna Giuliano, Kathy Baumgartner, Jennifer Herrick, Roger K Wolff

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 2 syntheses or guidelines pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Association between four MMP-9 polymorphisms and breast cancer risk: a meta-analysis.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Shaping Oncogenic Microenvironments: Contribution of Fibronectin.Frontiers in cell and developmental biology · 2024
    Review
  9. Association ofHealth science reports · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Recapitulating TumorigenesisFrontiers in bioengineering and biotechnology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Martha L SlatteryDepartment of Medicine, University of Utah, Salt Lake City, Utah, United States of America. marty.slattery@hsc.utah.edu
Esther John
Gabriela Torres-Mejia
Mariana Stern
Abbie Lundgreen
Lisa Hines
Anna Giuliano
Kathy Baumgartner
Jennifer Herrick
Roger K Wolff
University of Utah · USCancer Prevention Institute of California · USInstituto Nacional de Salud Pública · MXMoffitt Cancer Center · USUniversity of Colorado Colorado Springs · USUniversity of Louisville · USUniversity of Southern California · US

Funding

FOUR-CORNERS BREAST AND ENDOMETRIAL CANCER STUDYR01CA078682 · NCI · UNIVERSITY OF UTAH · PI SLATTERY, MARTHA OR MARTY L · 1999 to 2003
$4.0M
Disparities in Breast Cancer: Development and Survival in Hispanic and NHW WomenR01CA140002 · NCI · UNIVERSITY OF UTAH · PI SLATTERY, MARTHA L · 2009 to 2013
$3.1M
NCI NIH HHS R01 CA078682NCI NIH HHS R01 CA140002
6 · The paper itself

Abstract

Matrix metalloproteinases (MMPs) contribute to cancer through their involvement in cancer invasion and metastasis. We evaluated genetic variation in MMP1 (9 SNPs), MMP2 (8 SNPs), MMP3 (4 SNPs), and MMP9 (3 SNPs) and breast cancer risk among Hispanic (2111 cases, 2597 controls) and non-Hispanic white (NHW) (1481 cases, 1586 controls) women in the Breast Cancer Health Disparities Study. Ancestral informative markers (n = 104) were assessed to determine Native American (NA) ancestry. MMP1 [4 single nucleotide polymorphisms (SNPs)] and MMP2 (2 SNPs) were associated with breast cancer overall. MMP1 rs996999 had strongest associations among women with the most NA ancestry (OR 1.61,95% CI 1.09,2.40) as did MMP3 rs650108 (OR 1.36, 95% CI 1.05,1.75) and MMP9 rs3787268 (OR 1.52, 95% CI 1.09,2.13). The adaptive rank truncated product (ARTP) showed a significant pathway p(artp)  value of 0.04, with a stronger association among women with the most NA ancestry (p(artp) = 0.02). Significant pathway genes using the ARTP were MMP1 for all women (p(artp) = 0.02) and MMP9 for women with the most NA ancestry (p(artp) = 0.024); MMP2 was borderline significant overall (p(artp) =0.06) and MMP1 and MMP3 were borderline significant for women with the most NA ancestry (p(artp) = 0.07 and 0.06 respectively). MMP1 and MMP2 were associated with ER+/PR+ and ER+/PR-tumors; MMP3 and MMP9 were associated with ER-/PR- tumors. The pathway was highly significant with survival (p(artp) = 0.0041) with MMP2 having the strongest gene association (p(artp) = 0.0007). Our findings suggest that genetic variation in MMP genes influence breast cancer development and survival in this genetically admixed population.

Indexed as

AdultBreast NeoplasmsFemaleGenetic Predisposition to DiseaseHispanic or LatinoHumansMatrix Metalloproteinase 1Matrix Metalloproteinase 2Matrix Metalloproteinase 3Matrix Metalloproteinase 9Matrix MetalloproteinasesMiddle AgedPolymorphism, Single NucleotideRisk FactorsWhite PeopleMatrix Metalloproteinase 1Matrix Metalloproteinase 2Matrix Metalloproteinase 3Matrix Metalloproteinase 9Matrix Metalloproteinases

Identifiers

PMID23696797
PMCPMC3655963
OpenAlexW2078617909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.